Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer-Reference-Cited by-同舟云学术

Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer

Author:

Naito Seiji¹,Koga Hirofumi¹,Yamaguchi Akito²,Fujimoto Naohiro³,Hasui Yoshihiro⁴,Kuramoto Hiroshi⁵,Iguchi Atsushi⁶,Kinukawa Naoko⁷,

Affiliation:

1. Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

2. Department of Urology, Harasanshin General Hospital, Fukuoka, Japan

3. Department of Urology, University of Occupational and Environmental Health, Miyazaki, Japan

4. Department of Urology, Kitakyushu and Miyazaki Medical College, Miyazaki, Japan

5. Department of Urology, Moji Rousai Hospital, Miyazaki, Japan

6. Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

7. Department of Medical Information on Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Non-muscle-invasive bladder cancer (Ta, T1, and CIS);Jone,2007

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Bacteria-based cancer therapy: Looking forward;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07